The largest database of trusted experimental protocols

Moloney murine leukemia virus

Manufactured by Takara Bio
Sourced in Japan

The Moloney murine leukemia virus is a laboratory tool used for viral transduction in cell biology research. It functions as a retroviral vector for gene delivery and expression in various cell lines.

Automatically generated - may contain errors

5 protocols using moloney murine leukemia virus

1

Quantitative Analysis of miRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from the cells and tissues with TRIzol reagent (Thermo Fisher Scientific) and reversely transcribed to cDNA using a stem-loop reverse transcription primer for miRNA detection. The reverse transcription of miR-132 and internal control U6 was performed using reverse transcriptase Moloney murine leukemia virus (TaKaRa, Tokyo, Japan). Quantitative real-time polymerase chain reaction (PCR) was performed using SYBR Premix ex Taq (TaKaRa) following the manufacturer’s protocol and using a preheated real-time instrument (Thermo Fisher Scientific). Three independent experiments were conducted to analyze the relative gene expression, and each sample was tested in triplicate. All the mRNA quantification data were normalized by the Ct value of U6 (internal control) using a 2−ΔΔCt relative quantification method.
+ Open protocol
+ Expand
2

Quantitative Analysis of Enterovirus 71 Replication

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vero cells were seeded in 6-well plates 1 day prior to the assay. The cells were inoculated with equal amount of HP strain or CCA strain, followed by incubation at 4°C for 1 hour. After synchronized viral adsorption, the cells were washed twice with PBS to remove the unbound virions. Then the cells were incubated at 37°C in the medium of DMEM. The virus infected cells were collected by Trizol reagent at indicated time points post infection. For detection of replication of negative strand genomic RNA, the total RNAs of the infected cell samples were extracted and subjected to RT-PCR quantification as described previously. In brief, cDNA was synthesized with reverse transcriptase of Moloney murine leukemia virus (Takara) using the primer 1F (5’-ttaaaacagcctgtgggttg-3’) specific to the negative strand genomic RNA. Then the cDNA of negative strand genomic RNA was quantified by real time PCR (SsoFast EvaGreen Supermix, Takara) using the primers EV71-RT-F (5’-gcagcccaaaagaacttcac-3’) and EV71-RT-R (5’-atttcagcagcttggagtgc-3’) that are located in the capsid protein VP1 gene. The gene of GAPDH was used as the internal control to normalize the total RNA of the sample. The negative strand RNA amount were expressed as fold increase relative to that of sample collected at 0.5 hour post infection.
+ Open protocol
+ Expand
3

Quantitative RT-PCR Gene Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
RT-qPCR was performed using the same batch of specimens. The RNAs were extracted using TRIzol reagent, reverse transcribed using Moloney murine leukemia virus (Takara Biotechnology Co., Ltd., Shiga, Japan), and separately subjected to PCR amplification. The primers were synthesized by Invitrogen (Thermo Fisher Scientific, Inc.) using GAPDH as the reference gene. The primer sequences, amplification length and annealing temperature are reported previously [10 (link)]. The reaction procedure was as follows: Initial denaturation at 94°C for 5 min; followed by 35 cycles for denaturation at 94°C for 30 sec, annealing for 30 sec and elongation at 72°C for 30 sec; each sample was assayed in triplicate. A temperature range of 65–95°C was selected for drawing melting curves.
+ Open protocol
+ Expand
4

RT-qPCR Validation of Microarray Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six genes with significant (P<0.05) differential expressions [myosin light chain kinase (MYLK), polycystin 1, transient receptor potential channel interacting (PKD-1), myosin heavy chain 11 (MYH11), superoxide dismutase 3, extracellular (SOD3), filamin A (FLNA) and transgelin (TAGLN)] were selected to verify the microarray results using RT-qPCR. The microarray assay and RT-qPCR were performed using the same batch of specimens. The RNAs were extracted using TRIzol reagent, reverse transcribed using Moloney murine leukemia virus (Takara Biotechnology Co., Ltd., Shiga, Japan), and separately subjected to PCR amplification. The primers were synthesized by Invitrogen (Thermo Fisher Scientific, Inc.) using GAPDH as the reference gene. The primer sequences, amplification length and annealing temperature are presented in Table I. The reaction procedure was as follows: Initial denaturation at 94°C for 5 min; followed by 35 cycles for denaturation at 94°C for 30 sec, annealing for 30 sec and elongation at 72°C for 30 sec; each sample was assayed in triplicate. A temperature range of 65–95°C was selected for drawing melting curves.
+ Open protocol
+ Expand
5

Quantification of Viral RNA by RT-qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
For viral RNA quantification, 250 μl of the purified virus sample was used for RNA extraction by TRIzol LS (Invitrogen) according to the manufacturer’s instruction. cDNA was synthesized with reverse transcriptase of Moloney murine leukemia virus (Takara), and its level was quantified by real time PCR (Sso Fast Eva Green Supermix, Takara) using the primers EV71-RT-F (5’-gcagcccaaaagaacttcac-3’) and EV71-RT-R (5’-atttcagcagcttggagtgc-3’) that are located in the capsid protein VP1 gene. The copy number of the viral genome RNA was calculated by generating a standard curve using serial dilutions of plasmid containing DNA sequence for the VP1 gene.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!